Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma.

Literature DB >> 9824140

Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma.

A Lonardo¹, P Tarugi, G Ballarini, A Bagni.

Abstract

Entities: Disease

Mesh：

Substances：
Apolipoproteins B

Year: 1998 PMID： 9824140 DOI： 10.1023/a:1026646618643

Source DB: PubMed Journal: Dig Dis Sci ISSN： 0163-2116 Impact factor: 3.199

× No keyword cloud information.

41 in total

1. [Cryptogenetic liver cirrhosis with hypobetalipoproteinemia. Typing of the HLA histocompatibility system].

Authors: V Di Piazza; M Cacitti
Journal: Minerva Med Date: 1992-04 Impact factor: 4.806

2. Hepatocellular carcinoma associated with second primary malignancy.

Authors: D Y Lin; Y F Liaw; C S Wu; C S Chang-Chien; P C Chen; T J Chen
Journal: Liver Date: 1987-04

3. Characteristics of hepatocellular carcinoma associated with extrahepatic primary malignancies in southern Japan.

Authors: M Shimada; K Takenaka; Y Fujiwara; T Gion; K Shirabe; T Nishizaki; K Yanaga; K Sugimachi
Journal: Am J Gastroenterol Date: 1996-04 Impact factor: 10.864

4. A truncated species of apolipoprotein B, B-83, associated with hypobetalipoproteinemia.

Authors: R V Farese; A Garg; V R Pierotti; G L Vega; S G Young
Journal: J Lipid Res Date: 1992-04 Impact factor: 5.922

5. Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong.

Authors: K C Lam; M C Yu; J W Leung; B E Henderson
Journal: Cancer Res Date: 1982-12 Impact factor: 12.701

6. A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer.

Authors: K Takayasu; H Kasugai; S Ikeya; Y Muramatsu; N Moriyama; M Makuuchi; S Yamazaki; S Hirohashi
Journal: Cancer Date: 1992-01-01 Impact factor: 6.860

7. Hepatocellular carcinoma with extrahepatic primary neoplasms.

Authors: M Kanematsu; T Imaeda; Y Yamawaki; Y Hirose; A Inoue; H Goto; H Doi
Journal: Gastrointest Radiol Date: 1992

8. Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.

Authors: F Trevisani; P E D'Intino; P Caraceni; M Pizzo; G F Stefanini; A Mazziotti; G L Grazi; G Gozzetti; G Gasbarrini; M Bernardi
Journal: Cancer Date: 1995-05-01 Impact factor: 6.860

9. Association of hepatocellular carcinoma in North American patients with extrahepatic primary malignancies.

Authors: U C Nzeako; Z D Goodman; K G Ishak
Journal: Cancer Date: 1994-11-15 Impact factor: 6.860

10. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection.

Authors: T Livraghi; A Giorgio; G Marin; A Salmi; I de Sio; L Bolondi; M Pompili; F Brunello; S Lazzaroni; G Torzilli
Journal: Radiology Date: 1995-10 Impact factor: 11.105

12 in total

1. Clinical utility gene card for: Familial Hypobetalipoproteinaemia (APOB).

Authors: John R Burnett; Damon A Bell; Amanda J Hooper; Robert A Hegele
Journal: Eur J Hum Genet Date: 2012-05-16 Impact factor: 4.246

2. A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia.

Authors: Angelo B Cefalù; James P Pirruccello; Davide Noto; Stacey Gabriel; Vincenza Valenti; Namrata Gupta; Rossella Spina; Patrizia Tarugi; Sekar Kathiresan; Maurizio R Averna
Journal: Arterioscler Thromb Vasc Biol Date: 2013-05-30 Impact factor: 8.311

Review 3. Hypobetalipoproteinemia and abetalipoproteinemia.

Authors: Francine K Welty
Journal: Curr Opin Lipidol Date: 2014-06 Impact factor: 4.776

Review 4. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Authors: Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal: World J Gastroenterol Date: 2014-09-28 Impact factor: 5.742

Review 5. Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.

Authors: Robert A Hegele; Samuel S Gidding; Henry N Ginsberg; Ruth McPherson; Frederick J Raal; Daniel J Rader; Jennifer G Robinson; Francine K Welty
Journal: Arterioscler Thromb Vasc Biol Date: 2015-09-16 Impact factor: 8.311